Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discusses the importance of collaboration in cancer research at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Prof. Schuler describes how there use to be reluctance between companies and academia to collaborate on combination therapies. However as the use of combination therapies to treat cancer is becoming a more popular strategy, cooperation has increased. Collaboration is necessary to support progress in the field of cancer therapy.
The importance of collaboration in cancer research
